Acceleron adds 2 new sites for ACE-083 clinical trial

Cambridge, Massachusetts-based Acceleron Pharma, Inc., is now recruiting adults with FSH muscular dystrophy for a Phase 2 clinical trial of ACE-083 at sites in Kansas City, KS, and Rochester, NY, in addition to St. Louis, MO. For more information, visit our page “Find a Clinical Study.”

Correction: In our email alert, we mentioned Cleveland, OH, as a future trial site. The correct location is Columbus, OH.

ردان على “Acceleron adds 2 new sites for ACE-083 clinical trial”

  1. يقول Nicholas Esposito:

    You should do a study near Hickory, NC. I am a fitness fanatic and would love to test this out.